In vivo, ApoA-I may undergo oxidation in the oxidative environments of plaques or from myeloperoxidase, an enzyme involved in atherosclerosis [39,40], leading to amyloid fibril formation [21,22]. Here, APOA1 is linked to atherosclerosis.